CWG
PFE icon

Cornerstone Wealth Group’s Pfizer PFE Stock Holding History

Cornerstone Wealth Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Buy
22,161
+1,670
+8% +$44.5K 0.04% 211
2025
Q4 		$510K Buy
20,491
+132
+0.6% +$3.33K 0.03% 203
2025
Q3 		$519K Buy
20,359
+2,480
+14% +$61.2K 0.04% 193
2025
Q2 		$433K Buy
17,879
+881
+5% +$20.5K 0.03% 199
2025
Q1 		$431K Buy
16,998
+268
+2% +$7.01K 0.04% 183
2024
Q4 		$444K Sell
16,730
-100
-0.6% -$2.71K 0.04% 174
2024
Q3 		$487K Buy
16,830
+299
+2% +$8.72K 0.04% 168
2024
Q2 		$463K Buy
16,531
+1,119
+7% +$30.8K 0.04% 166
2024
Q1 		$428K Buy
15,412
+6,452
+72% +$179K 0.04% 170
2023
Q4 		$258K Buy
8,960
+399
+5% +$12.1K 0.04% 130
2023
Q3 		$284K Sell
8,561
-686
-7% -$24.3K 0.05% 126
2023
Q2 		$339K Sell
9,247
-122,769
-93% -$4.78M 0.06% 120
2023
Q1 		$5.39M Buy
132,016
+3,536
+3% +$153K 0.96% 29
2022
Q4 		$6.58M Buy
128,480
+3,401
+3% +$163K 1.25% 20
2022
Q3 		$5.47M Buy
125,079
+116,125
+1,297% +$5.64M 1.21% 23
2022
Q2 		$469K Sell
8,954
-9
-0.1% -$459 0.1% 98
2022
Q1 		$464K Sell
8,963
-2,664
-23% -$138K 0.09% 118
2021
Q4 		$687K Buy
11,627
+914
+9% +$45.3K 0.12% 107
2021
Q3 		$461K Buy
10,713
+580
+6% +$25.7K 0.08% 118
2021
Q2 		$407K Sell
10,133
-66
-0.6% -$2.57K 0.08% 119
2021
Q1 		$403K Sell
10,199
-65,423
-87% -$2.32M 0.08% 127
2020
Q4 		$2.78M Sell
75,622
-5,167
-6% -$190K 0.68% 52
2020
Q3 		$2.81M Buy
80,789
+72,180
+838% +$2.53M 0.77% 36
2020
Q2 		$267K Sell
8,609
-218
-2% -$7.41K 0.07% 106
2020
Q1 		$273K Sell
8,827
-339
-4% -$11.6K 0.1% 93
2019
Q4 		$341K Buy
9,166
+463
+5% +$16.5K 0.09% 117
2019
Q3 		$297K Sell
8,703
-39,446
-82% -$1.43M 0.07% 108
2019
Q2 		$1.98M Sell
48,149
-6,950
-13% -$276K 0.53% 47
2019
Q1 		$2.22M Buy
+55,099
New +$2.21M 0.56% 39

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cornerstone Wealth Group's PFE Position: Q1 2026 in Review

Cornerstone Wealth Group increased its Pfizer (PFE) stake by 8.1% in Q1 2026, buying an estimated $44.5K and bringing the position to 22,161 shares worth $605K. The position accounts for 0.04% of the portfolio, ranked #211.

Cornerstone Wealth Group first reported a position in PFE in Q1 2019 and has held it in 29 quarters since. The position peaked at $6.58M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cornerstone Wealth Group held 22,161 shares of Pfizer worth $605K as of Q1 2026.
  • Cornerstone Wealth Group bought 1,670 Pfizer shares in Q1 2026, an estimated $44.5K.
  • Pfizer made up 0.04% of Cornerstone Wealth Group's portfolio in Q1 2026, its #211 holding.
  • Cornerstone Wealth Group first reported a position in Pfizer in Q1 2019 and has held it in 29 quarters since.
  • Cornerstone Wealth Group's Pfizer position peaked at $6.58M in Q4 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cornerstone Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.